+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Medical Cannabis Market by Product Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • ID: 5521589
  • Report
  • October 2021
  • Region: Global
  • 229 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Aurora marijuana Inc.
  • Canopy Growth Corporation
  • Cronos Group Inc.
  • Maricann Group Inc.
  • Medical Marijuana Inc.
  • OrganiGram Holding Inc.
The global medical cannabis market was valued at $6,822.21 million in 2020 and is projected to reach $53,883.46 million by 2030 registering a CAGR of 23.6% from 2021 to 2030.



Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family. It was used medicinally in ancient Indian, Chinese, Egyptian, and Islamic cultures. Medical cannabis is the crude, unprocessed, and whole marijuana plant extract, which finds application in the treatment of a wide range of diseases and symptoms, including cancer, chronic pain, depression, arthritis, diabetes, glaucoma, migraines, epilepsy, multiple sclerosis, acquired immunodeficiency syndrome (AIDS), amyotrophic lateral sclerosis (ALS), Alzheimer’s, post-traumatic stress disorder (PTSD), Parkinson’s, and Tourette’s. Owing to its therapeutic benefits, cannabis has been approved for medical use in numerous countries such as Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Germany, Italy, Mexico, Spain, the UK, the U.S., and Uruguay, with varying degrees of legal restrictions.

The key factors that drive growth of the medical cannabis market include legalization of cannabis across various regions and rise in awareness among consumers regarding health benefits of cannabis and its growing medical application such as treatment of wide range of diseases and symptoms. In addition, novel product development along with increased R&D activities boost growth of the medical cannabis market. However, complex regulatory structure for the usage of cannabis and social stigma related to cannabis use hamper growth of the market. In contrast, cannabis legalization in Asia-Pacific is expected to offer lucrative growth opportunities for players in the medical cannabis market.

The global medical cannabis market is segmented on the basis of product type, application, end user, and region to provide a detailed assessment of the market. By product type, it is bifurcated into buds/marijuana flower and cannabis extracts. The cannabis extract segment includes oil, tinctures, and others, which include hash and dabs. The applications covered in the study include chronic pain, mental disorders, cancer, and others include arthritis, epilepsy, migraine, and others. Depending on end user, the market is categorized into pharmaceutical and research & development centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the medical cannabis market along with the current trends and future estimations to explain the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of medical cannabis used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS


By Product Type

  • Buds/Marijuana Flower
  • Cannabis Extracts
  • Oil
  • Tinctures
  • Others

By Application

  • Chronic Pain
  • Mental Disorders
  • Cancer
  • Others

By End-User

  • Pharmaceutical
  • Research & Development Centers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • Italy
  • Denmark
  • Poland
  • UK
  • Rest of Europe
  • Asia-Pacific
  • Thailand
  • Australia
  • New Zealand
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Aurora marijuana Inc.
  • Canopy Growth Corporation
  • Cronos Group Inc.
  • Maricann Group, Inc.
  • Medical Marijuana, Inc.
  • OrganiGram Holding Inc.
  • Terra Tech Corp.
  • Tikun Olam Ltd.
  • Tilray, Inc.
  • VIVO Cannabis Inc.
Frequently Asked Questions about the Global Medical Cannabis Market

What is the estimated value of the Global Medical Cannabis Market?

The Global Medical Cannabis Market was estimated to be valued at $6822.2 million in 2020.

What is the growth rate of the Global Medical Cannabis Market?

The growth rate of the Global Medical Cannabis Market is 23.0%, with an estimated value of $53883.5 million by 2030.

What is the forecasted size of the Global Medical Cannabis Market?

The Global Medical Cannabis Market is estimated to be worth $53883.5 million by 2030.

Who are the key companies in the Global Medical Cannabis Market?

Key companies in the Global Medical Cannabis Market include Aurora marijuana Inc., Canopy Growth Corporation, Cronos Group Inc., Maricann Group Inc., Medical Marijuana Inc., OrganiGram Holding Inc., Terra Tech Corp. and Tilray Inc. and VIVO Cannabis Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aurora marijuana Inc.
  • Canopy Growth Corporation
  • Cronos Group Inc.
  • Maricann Group Inc.
  • Medical Marijuana Inc.
  • OrganiGram Holding Inc.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in legalization of cannabis across various regions
3.5.1.2. Rise in awareness among consumers regarding health benefits of cannabis and its growing medical application
3.5.1.3. Novel product development with increased R & D activities
3.5.2. Restraints
3.5.2.1. Complex regulatory structure for the usage of cannabis
3.5.2.2. Social stigma related to cannabis use
3.5.3. Opportunities
3.5.3.1. Emergence of cannabis legalization in Asia Pacific
3.5.4. Impact analysis
3.6. COVID-19 Impact analysis on the medical cannabis market

CHAPTER 4: MEDICAL CANNABIS MARKET, BY PRDUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Buds / marijuana Flower
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Cannabis Extracts
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.3.4. Market size and forecast, by type
4.3.5. Oil
4.3.5.1. Market size and forecast
4.3.6. Tinctures
4.3.6.1. Market size and forecast
4.3.7. Others
4.3.7.1. Market size and forecast

CHAPTER 5: MEDICAL CANNABIS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Chronic Pain
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Mental Disorders
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Cancer
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country

CHAPTER 6: MEDICAL CANNABIS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Pharmaceutical
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Research and Development Centers
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country

CHAPTER 7: MEDICAL CANNABIS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. medical cannabis market, by product type
7.2.2.1.2. U.S. medical cannabis market, by application
7.2.2.1.3. U.S. medical cannabis market, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada medical cannabis market, by product type
7.2.2.2.2. Canada medical cannabis market, by application
7.2.2.2.3. Canada medical cannabis market, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico medical cannabis market, by product type
7.2.2.3.2. Mexico medical cannabis market, by application
7.2.2.3.3. Mexico medical cannabis market, by end user
7.2.3. North America market size and forecast, by product type
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany medical cannabis market, by product type
7.3.2.1.2. Germany medical cannabis market, by application
7.3.2.1.3. Germany medical cannabis market, by end user
7.3.2.2. Italy
7.3.2.2.1. Italy medical cannabis market, by product type
7.3.2.2.2. Italy medical cannabis market, by application
7.3.2.2.3. Italy medical cannabis market, by end user
7.3.2.3. Denmark
7.3.2.3.1. Denmark medical cannabis market, by product type
7.3.2.3.2. Denmark medical cannabis market, by application
7.3.2.3.3. Denmark medical cannabis market, by end user
7.3.2.4. Poland
7.3.2.4.1. Poland medical cannabis market, by product type
7.3.2.4.2. Poland medical cannabis market, by application
7.3.2.4.3. Poland medical cannabis market, by end user
7.3.2.5. UK
7.3.2.5.1. UK medical cannabis market, by product type
7.3.2.5.2. UK medical cannabis market, by application
7.3.2.5.3. UK medical cannabis market, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe medical cannabis market, by product type
7.3.2.6.2. Rest of Europe medical cannabis market, by application
7.3.2.6.3. Rest of Europe medical cannabis market, by end user
7.3.3. Europe market size and forecast, by product type
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Thailand
7.4.2.1.1. Thailand medical cannabis market, by product type
7.4.2.1.2. Thailand medical cannabis market, by application
7.4.2.1.3. Thailand medical cannabis market, by end user
7.4.2.2. Australia
7.4.2.2.1. Australia medical cannabis market, by product type
7.4.2.2.2. Australia medical cannabis market, by application
7.4.2.2.3. Australia medical cannabis market, by end user
7.4.2.3. New Zealand
7.4.2.3.1. New Zealand medical cannabis market, by product type
7.4.2.3.2. New Zealand medical cannabis market, by application
7.4.2.3.3. New Zealand medical cannabis market, by end user
7.4.2.4. Rest of Asia-Pacific
7.4.2.4.1. Rest of Asia-Pacific medical cannabis market, by product type
7.4.2.4.2. Rest of Asia-Pacific medical cannabis market, by application
7.4.2.4.3. Rest of Asia-Pacific medical cannabis market, by end user
7.4.3. Asia-Pacific market size and forecast, by product type
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil medical cannabis market, by product type
7.5.2.1.2. Brazil medical cannabis market, by application
7.5.2.1.3. Brazil medical cannabis market, by end user
7.5.2.2. South Africa
7.5.2.2.1. South Africa medical cannabis market, by product type
7.5.2.2.2. South Africa medical cannabis market, by application
7.5.2.2.3. South Africa medical cannabis market, by end user
7.5.2.3. Rest of LAMEA
7.5.2.3.1. Rest of LAMEA medical cannabis market, by product type
7.5.2.3.2. Rest of LAMEA medical cannabis market, by application
7.5.2.3.3. Rest of LAMEA medical cannabis market, by end user
7.5.3. LAMEA market size and forecast, by product type
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES
8.1. Aurora marijuana Inc.
8.1.1. Company overview
8.1.2. Operating business segments
8.1.3. Product portfolio
8.1.4. Business performance
8.1.5. Key strategic moves and developments
8.2. Canopy Growth Corporation
8.2.1. Company overview
8.2.2. Operating business segments
8.2.3. Product portfolio
8.2.4. Business performance
8.2.5. Key strategic moves and developments
8.3. Cronos Group Inc.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Maricann Group, Inc.
8.4.1. Company overview
8.4.2. Operating business segments
8.4.3. Product portfolio
8.5. Medical Marijuana, Inc.
8.5.1. Company overview
8.5.2. Operating business segments
8.5.3. Product portfolio
8.5.4. Business performance
8.5.5. Key strategic moves and developments
8.6. OrganiGram Holding Inc.
8.6.1. Company overview
8.6.2. Operating business segments
8.6.3. Product portfolio
8.6.4. Business performance
8.6.5. Key strategic moves and developments
8.7. Terra Tech Corporation
8.7.1. Company overview
8.7.2. Operating business segments
8.7.3. Product portfolio
8.7.4. Business performance
8.7.5. Key strategic moves and developments
8.8. Tikun Olam Ltd.
8.8.1. Company overview
8.8.2. Operating business segments
8.8.3. Product portfolio
8.9. Tilray, Inc.
8.9.1. Company overview
8.9.2. Operating business segments
8.9.3. Product portfolio
8.9.4. Business performance
8.9.5. Key strategic moves and developments
8.10. VIVO Cannabis Inc.
8.10.1. Company overview
8.10.2. Operating business segments
8.10.3. Product portfolio
8.10.4. Business performance
8.10.5. Key strategic moves and developments

List of Tables
TABLE 01. GLOBAL MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 02. MEDICAL CANNABIS MARKET FOR BUDS/MARIJUANA FLOWER, BY REGION, 2020-2030($MILLION)
TABLE 03. MEDICAL CANNABIS MARKET FOR CANNABIS EXTRACTS, BY REGION, 2020-2030($MILLION)
TABLE 04. MEDICAL CANNABIS MARKET, FOR CANNABIS EXTRACTS, BY TYPE, 2020-2030, ($MILLION)
TABLE 05. GLOBAL MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 06. MEDICAL CANNABIS MARKET FOR CHRONIC PAIN, BY REGION, 2020-2030($MILLION)
TABLE 07. MEDICAL CANNABIS MARKET FOR MENTAL DISORDERS, BY REGION, 2020-2030($MILLION)
TABLE 08. MEDICAL CANNABIS MARKET FOR CANCER, BY REGION, 2020-2030($MILLION)
TABLE 09. MEDICAL CANNABIS MARKET FOR OTHERS, BY REGION, 2020-2030($MILLION)
TABLE 10. GLOBAL MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 11. MEDICAL CANNABIS MARKET FOR PHARMACEUTICAL, BY REGION, 2020-2030($MILLION)
TABLE 12. MEDICAL CANNABIS MARKET FOR RESEARCH AND DEVELOPMENT CENTERS, BY REGION, 2020-2030($MILLION)
TABLE 13. MEDICAL CANNABIS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 14. NORTH AMERICA MEDICAL CANNABIS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 15. U.S. MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 16. U.S. MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 17. U.S. MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 18. CANADA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 19. CANADA MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 20. CANADA MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 21. MEXICO MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 22. MEXICO MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 23. MEXICO MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 24. NORTH AMERICA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 25. NORTH AMERICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 26. NORTH AMERICA MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 27. EUROPE MEDICAL CANNABIS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 28. GERMANY MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 29. GERMANY MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 30. GERMANY MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 31. ITALY MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 32. ITALY MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 33. ITALY MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 34. DENMARK MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 35. DENMARK MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 36. DENMARK MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 37. PLOAND MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 38. POLAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 39. POLAND MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 40. UK MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 41. UK MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 42. UK MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 43. REST OF EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 44. REST OF EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 45. REST OF EUROPE MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 46. EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 47. EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 48. EUROPE MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 49. ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 50. THAILAND MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 51. THAILAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 52. THAILAND MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 53. AUSTRALIA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 54. AUSTRALIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 55. AUSTRALIA MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 56. NEW ZEALAND MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 57. NEW ZEALAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 58. NEW ZEALAND MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 59. REST OF ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 60. REST OF ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 61. REST OF ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 62. ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 63. ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 64. ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 65. LAMEA MEDICAL CANNABIS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 66. BRAZIL MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 67. BRAZIL MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 68. BRAZIL MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 69. SOUTH AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 70. SOUTH AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 71. SOUTH AFRICA MEDICAL CANNABIS MARKET, BY END USER 2020-2030($MILLION)
TABLE 72. REST OF LAMEA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 73. REST OF LAMEA MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 74. REST OF LAMEA MEDICAL CANNABIS MARKET, END USER, 2020-2030($MILLION)
TABLE 75. LAMEA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 76. LAMEA MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 77. LAMEA MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 78. AURORA CANNABIS: COMPANY SNAPSHOT
TABLE 79. AURORA CANNABIS: OPERATING SEGMENTS
TABLE 80. AURORA CANNABIS: PRODUCT PORTFOLIO
TABLE 81. AURORA CANNABIS: KEY DEVELOPMENTS
TABLE 82. CANOPY GROWTH CORPORATION: COMPANY SNAPSHOT
TABLE 83. CANOPY GROWTH CORPORATION: OPERATING SEGMENTS
TABLE 84. CANOPY GROWTH CORPORATION: PRODUCT PORTFOLIO
TABLE 85. AURORA CANNABIS: KEY DEVELOPMENTS
TABLE 86. CRONOS GROUP INC.: SNAPSHOT
TABLE 87. CRONOS GROUP INC.: OPERATING SEGMENTS
TABLE 88. CRONOS GROUP INC.: PRODUCT PORTFOLIO
TABLE 89. CRONOS GROUP: KEY DEVELOPMENTS
TABLE 90. MARICANN GROUP, INC.: COMPANY SNAPSHOT
TABLE 91. MARICANN GROUP, INC.: OPERATING SEGMENTS
TABLE 92. MARICANN GROUP, INC.: PRODUCT PORTFOLIO
TABLE 93. MEDICAL MARIJUANA, INC.: COMPANY SNAPSHOT
TABLE 94. MEDICAL MARIJUANA, INC.: OPERATING SEGMENTS
TABLE 95. MEDICAL MARIJUANA, INC.: PRODUCT PORTFOLIO
TABLE 96. MEDICAL MARIJUANA: KEY DEVELOPMENTS
TABLE 97. ORGANIGRAM HOLDING INC.: COMPANY SNAPSHOT
TABLE 98. ORGANIGRAM HOLDING INC.: OPERATING SEGMENTS:
TABLE 99. ORGANIGRAM HOLDING INC.: PRODUCT PORTFOLIO
TABLE 100. ORGANIGRAM HOLDING: KEY DEVELOPMENTS
TABLE 101. TERRA TECH CORP.: COMPANY SNAPSHOT
TABLE 102. TERRA TECH CORP.: OPERATING SEGMENTS
TABLE 103. TERRA TECH CORP.: PRODUCT PORTFOLIO
TABLE 104. TERRA TECH CORP: KEY DEVELOPMENTS
TABLE 105. TIKUN OLAM LTD.: COMPANY SNAPSHOT
TABLE 106. TIKUN OLAM LTD.: OPERATING SEGMENTS
TABLE 107. TIKUN OLAM LTD.: PRODUCT PORTFOLIO
TABLE 108. TILRAY, INC.: COMPANY SNAPSHOT
TABLE 109. TILRAY, INC.: OPERATING SEGMENTS
TABLE 110. TILRAY, INC.: PRODUCT PORTFOLIO
TABLE 111. TILRAY, INC.: KEY DEVELOPMENTS
TABLE 112. VIVO CANNABIS INC.: COMPANY SNAPSHOT
TABLE 113. VIVO CANNABIS INC.: OPERATING SEGMENTS
TABLE 114. VIVO CANNABIS INC.: PRODUCT PORTFOLIO
TABLE 115. VIVO CANNABIS INC.: KEY DEVELOPMENTS

List of Figures
FIGURE 01. MEDICAL CANNABIS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2019-2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTES
FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
FIGURE 10. HIGH INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. COMPARATIVE ANALYSIS OF MEDICAL CANNABIS MARKET FOR BUDS/MARIJUANA FLOWER, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14. COMPARATIVE ANALYSIS OF MEDICAL CANNABIS MARKET FOR CANNABIS EXTRACTS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15. MEDICAL CANNABIS MARKET FOR OIL, 2020-2030, ($MILLION)
FIGURE 16. MEDICAL CANNABIS MARKET FOR TINCTURES, 2020-2030, ($MILLION)
FIGURE 17. MEDICAL CANNABIS MARKET FOR OTHERS, 2020-2030, ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS MEDICAL CANNABIS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF MEDICAL CANNABIS MARKET FOR MENTAL DISORDERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF MEDICAL CANNABIS MARKET FOR CANCER, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF MEDICAL CANNABIS MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22. COMPARATIVE ANALYSIS OF MEDICAL CANNABIS MARKET FOR PHARMACEUTICAL, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 23. COMPARATIVE ANALYSIS OF MEDICAL CANNABIS MARKET FOR RESEARCH AND DEVELOPMENT CENTERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 24. AURORA CANNABIS: NET SALES, 2019-2021 ($MILLION)
FIGURE 25. AURORA CANNABIS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 26. AURORA CANNABIS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 27. CANOPY GROWTH CORPORATION: NET SALES, 2019-2021 ($MILLION)
FIGURE 28. CANOPY GROWTH CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 29. CANOPY GROWTH CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 30. CRONOS GROUP INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 31. CRONOS GROUP INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32. CRONOS GROUP INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 33. MEDICAL MARIJUANA, INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 34. ORGANIGRAM HOLDING INC.: NET SALES, 2019-2021 ($MILLION)
FIGURE 35. TERRA TECH CORP.: NET SALES, 2018-2020 ($MILLION)
FIGURE 36. TILRAY, INC.: NET SALES, 2019-2021 ($MILLION)
FIGURE 37. TILRAY, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 38. TILRAY, INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 39. VIVO CANNABIS INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 40. VIVO CANNABIS INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 41. VIVO CANNABIS INC.: REVENUE SHARE BY REGION, 2020 (%)
Note: Product cover images may vary from those shown
  • Aurora marijuana Inc.
  • Canopy Growth Corporation
  • Cronos Group Inc.
  • Maricann Group Inc.
  • Medical Marijuana Inc.
  • OrganiGram Holding Inc.
  • Terra Tech Corp.
  • Tikun Olam Ltd.
  • Tilray Inc. and VIVO Cannabis Inc
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...